EichorEICHOR
Study identifier: NCT07551427 Synced from ClinicalTrials.gov · August 04, 2026
● Recruiting

A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis

Condition: Myelofibrosis  ·  Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

PhasePhase 2
Planned participants51
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is an open-label, single-arm, multi-center phase II study consisting of two cohorts. Cohort 1 evaluates the pharmacokinetics (PK) of TQ05105 in myelofibrosis participants with normal, mild, or moderate renal impairment to guide dosing. Cohort 2 evaluates the efficacy and safety of TQ05105 in participants with intermediate/high-risk myelofibrosis who are refractory, relapsed, or intolerant to prior Janus kinase (JAK) inhibitor therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Chunkang Chang, Doctor  ·  13764643870  ·  changchunkang7010@aliyun.com

Always discuss trial participation with your own doctor first.

Locations (24)

The First Affiliated Hospital of University of Science and Technology of ChinaHefei, Anhui, ChinaRecruiting
Fujian Medical University Union HospitalFuzhou, Fujian, ChinaRecruiting
Guangzhou First Municipal People's HospitalGuangzhou, Guangdong, ChinaRecruiting
The First Affiliated Hospital of Guangxi Medical UniversityNanning, Guangxi, ChinaRecruiting
Cangzhou People's Hospital rovinceCangzhou, Hebei, ChinaRecruiting
Affiliated Hospital of Chengde Medical CollegeChengde, Hebei, ChinaRecruiting
The Second Hospital of Hebei Medical UniversityShijiazhuang, Hebei, ChinaRecruiting
Xingtai People's HospitalXingtai, Hebei, ChinaRecruiting
Henan Cancer HospitalZhengzhou, Henan, ChinaRecruiting
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & TechnologyWuhan, Hubei, ChinaRecruiting
Union Hospital Tongji College Huazhong University of Science and TechnologyWuhan, Hubei, ChinaRecruiting
Zhuzhou Central HospitalZhuzhou, Hunan, ChinaRecruiting

+ 12 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →